Viagra or Cialis With Zepbound or Wegovy: Interactions and Timing

Neither the Viagra nor the Cialis prescribing information lists Zepbound, Wegovy, or any GLP-1 as an interacting drug, and the GLP-1 labels don't list PDE5 inhibitors either. The real issues are indirect: both drug types can lower blood pressure, GLP-1 side effects can leave you dehydrated, and GLP-1s slow stomach emptying, which may change how quickly a pill kicks in. That last point has never been studied for sildenafil or tadalafil.

What the labels actually say

The Viagra (sildenafil) prescribing information and the Cialis (tadalafil) prescribing information list the same core interaction groups: nitrates, riociguat, alpha-blockers, other blood pressure drugs, alcohol, and drugs that block the CYP3A4 liver enzyme (such as ritonavir, ketoconazole, and itraconazole). No GLP-1 drug appears in either label's interaction section.

On the GLP-1 side, the Zepbound label (revised August 2026) and the Wegovy label (revised June 2026) don't name PDE5 inhibitors. Their general warning is that they delay gastric emptying and may affect the absorption of oral drugs taken at the same time, with closer monitoring advised for drugs with a narrow therapeutic range, like warfarin or levothyroxine.

Source: Viagra PI, Cialis PI, Zepbound PI, Wegovy PI.

The blood pressure problem: when "no interaction" still bites

A drug interaction table won't show the most likely way this combination causes trouble. PDE5 inhibitors widen blood vessels and lower blood pressure a little. GLP-1s can lower it too, especially when nausea, vomiting, or diarrhea leave you short on fluids.

The numbers from the labels:

• Zepbound: hypotension in 1.6% of patients versus 0.1% on placebo in the obesity trials. It was more frequent in people on blood pressure drugs (2.2%) and "occurred in association with gastrointestinal adverse events and dehydration," per the Zepbound PI.
• Wegovy: hypotension-related reactions in 1.3% versus 0.4% on placebo, fainting in 0.8% versus 0.2%, and dizziness in 8% versus 4% at the 2.4 mg dose. Orthostatic hypotension was more common in patients on blood pressure drugs, per the Wegovy PI.
• Sildenafil plus amlodipine: in hypertensive patients taking amlodipine, 100 mg sildenafil caused an additional average drop of 8 mmHg systolic and 7 mmHg diastolic, per the Viagra PI.
• Tadalafil plus alcohol: the Cialis PI warns that substantial drinking (5 units or more) raises the risk of dizziness on standing.

Put those together and the risky scenario is easy to picture: the week after a dose increase, you've had diarrhea for two days, you're on a blood pressure pill, you have a couple of drinks, and you take a PDE5 inhibitor. None of those is dangerous alone. Combined, they make lightheadedness or fainting on standing more likely.

Dehydration and your kidneys: why it matters for tadalafil

Both GLP-1 labels warn about acute kidney injury in people who get dehydrated from GI side effects. The Wegovy label notes that some postmarketing cases required dialysis and advises monitoring kidney function in patients with fluid-losing reactions, especially when starting or increasing the dose. Zepbound carries a similar warning.

This connects to tadalafil because its dose depends on kidney function. The Cialis PI sets these limits:

• Creatinine clearance 30 to 50 mL/min, as-needed use: start at 5 mg, maximum 10 mg, no more than once every 48 hours.
• Creatinine clearance below 30 or on dialysis, as-needed use: maximum 5 mg, no more than once every 72 hours.
• Once-daily tadalafil for ED is not recommended below a clearance of 30.

If a bad stretch of vomiting leads to abnormal kidney labs, ask your prescriber whether your tadalafil dose still fits.

Does a GLP-1 slow down when Viagra or Cialis kicks in?

Honest answer: it's unstudied. None of the four labels includes data on it, and no dedicated trial has measured sildenafil or tadalafil absorption in people on semaglutide or tirzepatide.

What we can say from the labels is how sensitive each drug is to the stomach:

Source: Viagra PI, Cialis PI.

Sildenafil's absorption is sensitive to what's in your stomach. A heavy meal delays it by about an hour. It's plausible, though unproven, that slower gastric emptying on a GLP-1 could have a similar effect. If it does, it would be most likely to show up on days when GI side effects are worst. Tadalafil's absorption isn't affected by food, and its long half-life gives it a wide window, so a delay in onset matters less.

If sildenafil seems slower or weaker since you started a GLP-1, report that to your prescriber rather than doubling up. The Viagra label caps dosing at once per day.

Daily 5 mg tadalafil: the option that sidesteps timing

The Cialis PI lists three uses: ED, symptoms of benign prostatic hyperplasia (BPH), and both together. For BPH, or BPH plus ED, the labeled dose is 5 mg once daily. For ED alone, once-daily dosing starts at 2.5 mg and can go up to 5 mg. Steady blood levels are reached within about 5 days.

For a man over 50 who already takes a weekly GLP-1 and gets up at night to urinate, daily tadalafil can cover two problems with one pill and removes the "how long before?" guesswork. The trade-offs are a daily pill, steady low-level exposure, and the same blood pressure considerations above. Men on alpha-blockers like tamsulosin for BPH need their prescriber to manage the combination carefully, since both labels flag alpha-blockers.

When your ED needs change as weight comes off

The American Urological Association's ED guideline treats ED as a risk marker for underlying heart disease. It advises counseling men that diet and exercise changes may improve erectile function, and says PDE5 inhibitor doses should be titrated to the best effect.

In practice that means your PDE5 dose isn't set in stone. If your erections, blood pressure, or blood sugar change a lot during treatment, the right dose may change too. That could mean a lower dose, a switch from as-needed to daily, or the reverse. Your blood pressure medicines may also be reduced as you lose weight, which changes the hypotension math again. Bring it up at follow-ups; don't adjust on your own.

Practical rules of thumb to discuss with your prescriber

• Give your GLP-1 prescriber and your ED prescriber the same complete medication list, especially if they're different telehealth services.
• Ask whether to skip a PDE5 dose on days when you're actively vomiting, have diarrhea, or feel dizzy on standing.
• Ask what your hydration target should be during dose escalation weeks.
• If you take tamsulosin, doxazosin, or another alpha-blocker, ask whether your PDE5 starting dose should be lower.
• Tell any emergency team you take a PDE5 inhibitor if you have chest pain, so they don't give you nitroglycerin within the unsafe window.

Where this guide stops

This article covers label-listed interactions and practical use. It doesn't cover whether GLP-1s improve or worsen erectile function; that's a separate question with its own evidence. It also doesn't cover compounded or "research" versions of tadalafil, sildenafil, semaglutide, or tirzepatide. Compounded drugs are not FDA-approved, and their absorption and dosing may differ from the branded labels cited here.

Sources

1. Viagra (sildenafil citrate) Prescribing Information, Pfizer
2. Cialis (tadalafil) Prescribing Information, Eli Lilly
3. Zepbound (tirzepatide) Prescribing Information, Eli Lilly (revised 08/2026)
4. Wegovy (semaglutide) Prescribing Information, Novo Nordisk (revised 06/2026)
5. American Urological Association: Erectile Dysfunction Guideline (2018)

Medical disclaimer: This article is general information, not medical advice, and does not replace a licensed clinician who knows your history. Approvals, labels, coverage and prices change; check the linked sources and talk with your prescriber or pharmacist before making decisions about any medication.